Results 151 to 160 of about 2,535,651 (215)

Fecal microbiota transplantation in chronic liver disease: Current and future state of the art. [PDF]

Hepatol Commun
Bloom P, Khanna S.
europepmc   +1 more source

The C-reactive Protein-Triglyceride-Glucose Index in Relation to Liver Disease. [PDF]

Inquiry
Fang J, Liu L.
europepmc   +1 more source

Beyond cancer: CAR-T cells redefining liver disease therapy. [PDF]

JHEP Rep
Yashaswini CN, Bansal R.
europepmc   +1 more source

A transdisciplinary framework for managing metabolic dysfunction associated steatotic liver disease. [PDF]

Front Pharmacol
Kouser S, Sharma SV, Bhanu A, Kukkupuni SK, Vishnuprasad CN.   +4 more
europepmc   +1 more source

Sinusoidal cell-derived biomarker scores predict diagnosis and prognosis in chronic liver disease. [PDF]

BMC Med
Guixé-Muntet S, Fernández-Iglesias A, Lopez D, Tonina E, Fundora Y, Zagorska A, Gracia-Sancho J.   +6 more
europepmc   +1 more source

COLEC10 and COLEC11 are new serum biomarkers of chronic liver disease. [PDF]

Eur J Med Res
Yang T, Jing Y, Li K, Wang M, Ju S, Zhou Z, Cao X, Zhang M.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Alcoholic Liver Disease

Clinical Liver Disease, 2022
Content available: Author Interview and Audio Recording.
Fátima Higuera‐de‐la‐Tijera, Jorge Emilio Lira‐Vera, Oscar Morales‐Gutiérrez, Moisés Martínez‐Castillo, Zaira Medina‐Ávila, Alfredo Servín‐Caamaño, José Luis Pérez‐Hernández, Gabriela Gutiérrez‐Reyes   +7 more
openaire   +2 more sources